ScholarIQanswers from OpenAlex
Vivantes Klinikum
InstitutionResearch output, impact & collaborations
Vivantes Klinikum is a institution indexed in ScholarIQ from OpenAlex.
What is known about Vivantes Klinikum?
ScholarIQrecord summary
Vivantes Klinikum is a research organisation in Berlin, DE. OpenAlex records 6,075 works and 297,079 citations for it. 1,335 researchers list it as their most recent affiliation.
How many works does Vivantes Klinikum have?
ScholarIQindexed works
Vivantes Klinikum has 6,075 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Vivantes Klinikum have?
ScholarIQcitation count
Vivantes Klinikum has 297,079 citations in the OpenAlex counts ScholarIQ stores.
How many researchers are at Vivantes Klinikum?
ScholarIQresearcher count
Vivantes Klinikum has 1,335 researchers in the ScholarIQ index.
What is the average h-index at Vivantes Klinikum?
ScholarIQavg h-index
Vivantes Klinikum has an average h-index of 63 in OpenAlex.
What is the ROR of Vivantes Klinikum?
ScholarIQror
The ROR for Vivantes Klinikum is on the source record.
What is the OpenAlex record for Vivantes Klinikum?
ScholarIQopenalex
The OpenAlex for Vivantes Klinikum is on the source record.
Who are the most-cited researchers behind Vivantes Klinikum?
ScholarIQtop researchers by citations
What are the most-cited papers on Vivantes Klinikum?
ScholarIQmost cited works
Surviving Sepsis Campaign
R. Phillip Dellinger, Mitchell M. Levy, Andrew Rhodes, Djillali Annane, Herwig Gerlach, Steven M. Opal, Jonathan Sevransky, Charles L. Sprung, Ivor S. Douglas, Roman Jaeschke, Tiffany M. Osborn, Mark Nunnally, Sean R. Townsend, Konrad Reinhart, Ruth Kleinpell, Derek C. Angus, Clifford S. Deutschman, Flávia Ribeiro Machado, Gordon D. Rubenfeld, S. A. R. Webb, Richard Beale, Jean‐Louis Vincent, Rui P. Moreno
Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock, 2012
R.P. Dellinger, Mitchell M. Levy, Andrew Rhodes, Djillali Annane, Herwig Gerlach, Steven M. Opal, Jonathan Sevransky, Charles L. Sprung, Ivor S. Douglas, Roman Jaeschke, Tiffany M. Osborn, Mark Nunnally, Sean R. Townsend, Konrad Reinhart, Ruth Kleinpell, Derek C. Angus, Clifford S. Deutschman, Flávia Ribeiro Machado, Gordon D. Rubenfeld, S. A. R. Webb, Richard Beale, Jean‐Louis Vincent, Rui P. Moreno
Epidemiology of sepsis in Germany: results from a national prospective multicenter study
Christoph Engel, Frank M. Brunkhorst, Hans-Georg Bone, R. Brunkhorst, Herwig Gerlach, Stefan Grond, Matthias Gruendling, G. Huhle, Ulrich Jaschinski, Stefan John, Konstantin Mayer, Michael Oppert, D Olthoff, Michael Quintel, Max Ragaller, Rolf Rossaint, Frank Stüber, Norbert Weiler, Tobias Welte, Holger Bogatsch, Christiane S. Hartog, Markus Loeffler, Konrad Reinhart
Effect of Hydrocortisone on Development of Shock Among Patients With Severe Sepsis
Didier Keh, Evelyn Trips, Gernot Marx, Stefan P. Wirtz, Emad Abduljawwad, Sven Bercker, Holger Bogatsch, Josef Briegel, Christoph Engel, Herwig Gerlach, Anton Goldmann, Sven‐Olaf Kuhn, Lars Hüter, Andreas Meier‐Hellmann, Axel Nierhaus, Stefan Kluge, Josefa Lehmke, Markus Loeffler, Michael Oppert, Kerstin Resener, Dirk Schädler, Tobias Schuerholz, Philipp Simon, Norbert Weiler, A. Weyland, Konrad Reinhart, Frank M. Brunkhorst, for the SepNet–Critical Care Trials Group
Effect of Sodium Selenite Administration and Procalcitonin-Guided Therapy on Mortality in Patients With Severe Sepsis or Septic Shock
Frank Bloos, Evelyn Trips, Axel Nierhaus, Josef Briegel, Daren K. Heyland, Ulrich Jaschinski, Onnen Moerer, A. Weyland, Gernot Marx, Matthias Gründling, Stefan Kluge, Inès Kaufmann, K. Ott, Michael Quintel, Florian Jelschen, Patrick Meybohm, Sibylle Rademacher, Andreas Meier‐Hellmann, Stefan Utzolino, Udo X. Kaisers, Christian Putensen, Gunnar Elke, Maximilian Ragaller, Herwig Gerlach, Katrin Ludewig, Michael Kiehntopf, Holger Bogatsch, Christoph Engel, Frank M. Brunkhorst, Markus Loeffler, Konrad Reinhart, for SepNet Critical Care Trials Group
How much of the research on Vivantes Klinikum is open access?
ScholarIQopen access share
40%OPEN ACCESS